Skip to main content

Table 3 Identification results of potential biomarkers

From: Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Mode RT Measured mass VIP Formula Error (ppm) Identification Trenda
ESI+ 7.19 206.0438 4.78 C10H7NO4 1.0 Xanthurenic acid up
  2.59 338.1134 3.07 C7H14N2O6S 3.0 5-L-Glutamyl-taurine up
  2.30 105.0414 2.91 C10H18N4O6 -6.7 Argininosuccinic acid down
  1.18 220.1181 2.86 C9H17NO5 0.9 Pantothenic acid up
  1.93 162.0673 2.80 C12H22N2O6S 0.6 D-Pantothenoyl-L-cysteine down
  0.51 191.0206 2.18 C6H8O7 -2.0 Citric acid up
  3.08 164.0711 2.13 C9H9NO2 -3.0 3-Methyldioxyindole up
  8.04 426.3567 1.77 C25H47NO4 2.6 Vaccenyl carnitine up
  1.70 135.0641 1.70 C5H10O4 -8.1 2,3-Dihydroxyvaleric acid down
ESI- 2.74 143.1067 6.68 C8H16O2 -7.7 Caprylic acid up
  0.48 167.0201 3.11 C5H4N4O3 6.0 Uric acid down
  6.37 377.1454 2.79 C17H20N4O6 0.8 Riboflavin up
  3.30 173.0808 2.32 C8H14O4 -6.4 Suberic acid down
  0.40 124.0067 2.29 C2H7NO3S 6.4 Taurine up
  1.13 154.0505 1.53 C7H7NO3 2.6 3-Hydroxyanthranilic acid up
  2.24 157.0882 1.28 C8H14O3 1.9 3-Oxooctanoic acid down
  1. Metabolite change trend in MHG compared with MG